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Background: Patients with visual field defects after visual pathway lesion may experi-
ence reduced vision-related quality of life (vrQoL). It has not been clarified how vrQoL
impairments contribute to vision-related mental distress.
Methods: One hundred and eight subjects with visual field defects caused by optic
neuropathies (age M =57.6; SD=13.7 years) answered the National Eye Institute Visual-
Functioning Questionnaire 39 (NEI-VFQ) for vrQoL and the SF-12 Short Form Health Survey
for health-related quality of life. A 10 item composite of NEI-VFQ “visual functioning” and 5
items of “mental-health symptoms due to vision problems” were subjected to Rasch analy-
sis.The test battery comprised static and High Resolution Perimetry (HRP). Regression and
path analysis were used to investigate associations between QoL, mental distress, and
perimetry results.
Results: A higher level of “visual functioning” was associated with monocular impairment
and a larger remaining visual field compared to binocular impairment. Subjective “visual
functioning” but not visual field parameters predicted “mental-health symptoms due to
vision problems” which was the only variable associated with the SF-12 mental component
score. The SF-12 physical component score was less strongly associated with “mental-
health symptoms due to vision problems.” Here, reaction time in HRP and mean threshold
in perimetry were additional significant variables. Path analysis revealed a significant path
from remaining visual field via visual functioning on mental health.
Conclusion: Subjective consequences of visual impairments in everyday life impact mental
health rather than “objective” visual function loss as measured by perimetry. Since a higher
extent of vrQoL was related to lower levels of mental distress, the maintenance of vrQoL
could reduce and prevent mental distress due to vision problems. Patients with persist-
ing visual field defects may benefit from neuropsychological rehabilitation and supportive
therapies.
Keywords: vision-related quality of life, visual field defects, mental health, psychological distress, National Eye
Institute Visual-Functioning Questionnaire
INTRODUCTION
In optic neuropathy the axons of retinal ganglion cells are degen-
erated which results in visual field defects (You et al., 2013). These
defects lead to impairments in activities of daily living such as
reading, driving, or overall orientation (Kerkhoff, 1999). Besides
the impaired overall well-being and quality of life (QoL), the
risk for falling and trauma as well as social isolation in older
patients increases (Timmis and Pardhan, 2012; Sand et al., 2013).
In addition, the burden on the health care systems is tremendous
since visually impaired patients are often unable to continue their
occupation.
Impairments of vision which impact vision-related quality of
life (vrQoL) can be measured with the National Eye Institute
Visual-Functioning Questionnaire (NEI-VFQ) (Mangione et al.,
2001; Franke and Gall, 2008; Labiris et al., 2008). Designed for the
assessment of ophthalmologic diseases (Mangione et al., 2001) the
NEI-VFQ is a valid and reliable instrument which was frequently
used in studies focusing on the impact of visual field defects on
subjective vrQoL after central visual pathway lesions (Cole et al.,
2000; Beck et al., 2004; Raphael et al., 2006; Papageorgiou et al.,
2007; Gall et al., 2009, 2010; Wagenbreth et al., 2011; Galetta et al.,
2012; Walter et al., 2012; Jasse et al., 2013). It was demonstrated
that diminished vrQoL was significantly related to the size of the
visual field defect (e.g., Gall et al., 2009).
Additionally a number of studies have shown that the inci-
dence of neuropsychiatric conditions is high in visually impaired
patients with age-related macular degeneration (AMD) (Brody
et al., 2001; Mathew et al., 2011), diabetic retinopathy (Cox et al.,
1998; Robertson et al., 2006; Hahm et al., 2008; Trento et al., 2013),
refractive error (Owsley et al., 2007), myopia (Angi et al., 1996;
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Rupolo et al., 1997), and amblyopia (Koklanis et al., 2006). The
presence of visual field defects is a risk factor for mental distress,
especially for depressive symptoms (Zhang et al., 2013). Symptom
severity and emotional distress due to vision loss were related to
self-reported disability in low vision patients (Dreer et al., 2008).
Mathew et al. (2011) recently found that AMD led to depres-
sive symptoms indirectly via reduced health-related quality of life
(hrQoL) ratings obtained with the SF-36 Health Survey. Simi-
larly, in patients with postchiasmatic lesions it was shown that
the extent of the visual field defect itself did not directly influ-
ence perceived psychological distress, since SCL-90-R symptoms
were only reported when diminished vrQoL was present (Gall
et al., 2012). The present study aims at extending the previous
work by investigating to what extent decreased vrQoL contributes
to vision-related mental-health symptoms in patients with optic
neuropathies.
PATIENTS AND METHODS
SAMPLE
Data of 108 patients with optic neuropathies who took part in
baseline diagnostics of two clinical trials on non-invasive brain
stimulation from 2007 to 2011 were analyzed. The studies differed
in the way the questionnaires were answered. Some were filled out
at home (Sabel et al., 2011a), whereas the majority was answered
in an interview at our institute (Gall et al., 2013). Pooling the data
of these studies was justified since there were no differences with
respect to NEI-VFQ subscales of interest (p> 0.40) or SF-12 com-
ponent scores (p> 0.07). Furthermore, the two studies did not
differ with respect to lesion age [χ2(2, n= 108)= 0.36, p= 0.84]
or sex [χ2(1, n= 108)= 0.03, p= 0.86]. Table 1 gives a descrip-
tion of the sample. The main inclusion criterion was the presence
of visual field loss due to optic neuropathies with a lesion age of
at least 6 months.
All patients gave informed consent to participate in above men-
tioned clinical studies from which the present data were obtained.
These clinical studies were previously approved by the local ethics
committee and carried out in compliance with ethical standards
of the Declaration of Helsinki (1964).
DIAGNOSIS OF VISUAL FIELD DEFECTS
Visual field defects were assessed with monocular static standard-
automated perimetry using a Twinfield Oculus perimeter (Oculus,
Lynnwood, WA, USA) and High Resolution Perimetry (HRP;
Kasten et al., 1998) both with a combined chin-forehead-rest.
Monocular static perimetry was performed at a distance of
33 cm. Eye movements were monitored by a camera. Targets (size:
III/4 mm2, white, luminance: 318 cd/m2/0db, duration: 0.2 s, fast
threshold strategy, 53 positions) were presented on a background
with a constant luminance of 10 cd/m2. Patients had to push a
button whenever they detected a target.
Monocular HRP (25× 19 grid) was conducted at a distance of
42 cm on a 17′′monitor. Subjects were instructed to press the space
bar when a light stimulus or an isoluminant change in the color
of the fixation point occurred. The percentage of detected color
changes of the fixation point served as reliability parameter. The
percentage of correctly detected stimuli was registered as measure
of the remaining visual field in the total test area of HRP and in the
Table 1 | Description of patient sample.
Sample size 108
Age (years), M ±SD 57.58±13.67
Male n (%) 62 (57.4)
LESION AGE*
6–12 months n (%) 15 (13.9)
1–2 years n (%) 11 (10.2)
>2 years n (%) 82 (75.9)
TYPE OF LESION n (%)*
Optic atrophy of unknown etiology 6 (5.6)
Glaucoma 34 (31.5)
AION 24 (22.2)
Optic neuritis 12 (11.2)
Optic nerve compression (tumor) 8 (7.4)
NAION 17 (15.7)
Multiple sclerosis with optic neuritis 1 (0.9)
Optic atrophy after optic disk swelling 3 (2.8)
Optic atrophy after papillitis 1 (0.9)
Optic atrophy after papilledema 1 (0.9)
Leber’s hereditary optic neuropathy 3 (2.8)
Stroke/thrombosis with optic atrophy 5 (4.6)
Congenital optic atrophy 3 (2.8)
AFFECTED EYES n (%)
Monocular impairment, one eye intact 41 (38.0)
Binocular impairment, both eyes defect 58 (53.7)
Binocular impairment, one eye blind 9 (8.3)
VISUAL PARAMETERS M ±SD
Detection accuracy in HRP (%) 48.6±27.7
Detection accuracy central 5° in HRP (%) 58.1±28.3
Reaction time in HRP (ms) 532±84
Foveal threshold (dB) in static perimetry 21.2±8.9
Mean threshold (dB) in static perimetry 10.9±6.4
*Because of dual diagnoses the sum of lesion age types and etiologies (%) is
above 100%.
central 5° (Figure 1). In case detection accuracy was larger than
95% in HRP the visual field was considered as intact. Additionally,
mean reaction time (ms) was recorded.
QoL INSTRUMENTS
The validated German 39-item version of the NEI-VFQ (Franke
et al., 1998) was administered. The instrument is well suited for
patients with central visual pathway lesions (see Introduction).
The questionnaire consists of 39 rating items with 12 subscales
which were recently subjected to missing validity (Dougherty and
Bullimore, 2010; Marella et al., 2010). As suggested by Rasch mod-
els a “visual functioning” scale consisting of 10 items according to
Marella et al. (2010) was calculated for vrQoL. For the purpose of
the present study the items of the original subscale “mental-health
symptoms due to vision problems” were combined to a second
scale of interest: (1) How much of the time do you worry about
your vision? (2) I feel frustrated a lot of the time because of my
vision, (3) I have much less control over what I do, because of my
vision, (4) I worry about doing things that will embarrass myself
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HRP - central 5° visual field 21x16.5° HRP visual field
35° static threshold perimetry
FIGURE 1 | Visual field measurements were obtained with standard
static perimetry and high resolution perimetry (HRP). In static
perimetry the foveal and the mean threshold (dB) of 53 test positions
were analyzed. In HRP the number of correctly detected stimuli was
registered in a grid of 25×19 test positions as measure of the remaining
visual field within a test area of 21° horizontally×16.5° vertically. By
overlapping three HRP tests, visual field areas were categorized as intact
(white spots: 3/3 detected stimuli at the respective position), partially
(relative) damaged (gray spots: 1/3 or 2/3 detected stimuli), or absolutely
impaired (black spots: 0/3 detected stimuli). The 5°-area of HRP was
separately analyzed to evaluate the impact of remaining central visual
field.
or others, because of my vision, and (5) I am often irritable because
of my vision. Rasch analysis was applied to both scales.
The German Short Form Health Survey SF-36 or SF-12 was
used to obtain measures of hrQoL (Bullinger and Kirchberger,
1998). The SF-12 was selected because it is more economical while
maintaining a high correlation to the original SF-36 scores (Gan-
dek et al., 1998). In contrast to the NEI-VFQ, validation studies
of the German SF-36 revealed similar intervals between response
categories (Bullinger and Kirchberger, 1998; Forero et al., 2013).
Therefore the items were treated as interval and combined to the
physical component score (PCS) and mental component score
(MCS) according to the manual.
STATISTICAL ANALYSIS
Demographic and clinical data were analyzed with SPSS 21.0
for Windows (IBM Deutschland GmbH, Ehningen). In order to
ensure interval-scaled NEI-VFQ item responses for subsequent
analyses WINMIRA 2001 (Scienceplus, Groningen) was used to
calculate an ordinale Rasch analysis for the two NEI-VFQ scores of
“visual functioning” (n= 103) and “mental-health symptoms due
to vision problems” (n= 108). Response categories were inverted
from zero to four in a way that a higher response category repre-
sents a higher ability, respectively a better QoL. The equidistance
model without distribution smoothing was applied because equal
response distances for items independent of their response dimen-
sion (agreement, frequency, or intensity) were not expected. For
evaluation of model fit Pearson χ2 was calculated. Usefulness of
individual items and response categories were rated according to
category thresholds and Q indices for discrimination. Person abil-
ities were estimated using warms weighted likelihood estimate
(WLE). Because of the small sample size the number of differ-
ent response patterns is presumably small. Therefore, the analysis
should be restricted to this study and χ2 is interpreted carefully.
Furthermore bootstrapping (400 samples) was chosen to evaluate
the fit of the Rasch model for the simulated distribution of the
calculated parameters.
A first multiple linear regression with backward inclusion: (i)
was applied to analyze the effects of different visual field parame-
ters on NEI-VFQ “visual functioning.” The following visual field
parameters were considered relevant: detection accuracy in HRP
(%), detection accuracy within central 5° in HRP (%), reaction
time in HRP (ms), foveal threshold (dB) in static perimetry, mean
threshold (dB) in static perimetry, and ocular functional state. The
ocular functional state was included since in patients with monoc-
ular visual impairment the intact eye may compensate the resulting
vision loss. The presence of one intact eye was used as reference for
dummy coding of the ocular functional state (monocular vision
impairment with one intact eye, binocular vision impairment with
residual vision on both eyes, and binocular vision impairment with
one blind eye).
Three further multiple regression were calculated to identify
potential predictors of: (ii)“mental-health symptoms due to vision
problems” (NEI-VFQ), (iii) mental aspects of hrQoL (MCS of the
SF-12), and (iv) physical aspects of hrQoL (PCS of the SF-12). Pre-
dictors were above mentioned visual field parameters, NEI-VFQ
“visual functioning,” and for regression (iii) and (iv) the NEI-VFQ
“mental-health symptoms due to vision problems” scale.
A pairwise exclusion of missing data was selected for all
regressions.
For path analysis [SPSS Amos 21 (IBM Deutschland GmbH,
Ehningen)] a maximum likelihood estimation was calculated
to examine direct and indirect effects of HRP detection accu-
racy on “mental-health symptoms due to vision problems”
via vrQoL. Missing data were estimated and error regression
weights were fixed to one. χ2, CFI, and RMSEA were used
as fit indices. p-Values< 0.05 were considered as statistically
significant.
RESULTS
Detection accuracy in HRP as a measure of remaining visual field
varies between 0.14 and 94.02%. The frequency distribution of
measured detection accuracy is depicted in Figure 2.
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FIGURE 2 | Frequency distribution of detection accuracy in HRP as a
measure of remaining visual field. Detection accuracy values below 30%
reflect severe damage, 30–70% moderate, and more than 70% mild visual
field damage.
The mean NEI-VFQ “visual functioning” score was 71.45
(SD= 20.86). Patients reported a mean score of “mental-health
symptoms due to vision problems” of 66.20 (SD= 21.55) which
was lowered in a clinically relevant extent when compared to
healthy controls (Labiris et al., 2008; Wagenbreth et al., 2011).
Neither sex nor lesion age significantly influenced “mental
health due to vision problems”(sex, U = 1328, p= 0.54; lesion age,
Kruskal–Wallis χ2(2)= 2.96, p= 0.23). Most pronounced subjec-
tive impairments were reported for item 3 “worries about vision”
and item 25 “worry to embarrass myself/others.” The remaining
items had similar response distributions with approximately two
thirds of patients reporting no significant impairment.
The Rasch model fitted for the NEI-VFQ “visual function-
ing” and “mental-health symptoms due to vision problems” scale
(p≥ 0.24). Bootstrapping revealed no significant deviation from
Rasch model (p≥ 0.52). The mean item location of NEI-VFQ
“visual functioning” was 0.00 (SD= 0.86) and mean person loca-
tion was 1.76 (SD= 1.85). Item locations varied from the easiest to
the most difficult item between−1.76 (“picking out and matching
own clothes”) and 0.96 (“reading ordinary print in newspapers”).
All thresholds were ordered without overlaps. According to the Q
index there was no significant deviation in discrimination com-
pared to the Rasch model (p> 0.19). The averaged reliability
coefficient was 0.92.
The subscale“mental-health symptoms due to vision problems”
showed a good fit to the model (χ2= 3150.44, p= 0.24) with a
mean item location of 0.00 (SD= 1.09) and mean person location
of 0.38 (SD= 0.23). Item locations reached from −0.96 (“being
irritable”) to 1.53 (“worries about vision”). All item thresholds
were ordered without any overlap (Figure 3). No significant devi-
ations in discrimination could be observed (p> 0.46). Response
frequencies for NEI-VFQ items assessing “mental-health symp-
toms due to vision problems”and person parameters are illustrated
in Figure 4. Reliability was 0.79.
Regression results of visual field parameters on NEI-VFQ
“visual functioning” are shown in Table 2. The only significant
predictors in the regression of NEI-VFQ “visual functioning”
on visual field parameters were the ocular functional state and
FIGURE 3 | Visual inspection of threshold parameters reveal ordered
thresholds for each NEI-VFQ item assessing “mental-health symptoms
due to vision problems”. For Rasch analysis items were inverted in a way
that a higher response category represents a higher ability.
HRP detection accuracy with an adjusted R2 of 0.37. The model
implies that patients with binocular impairment but some pre-
served vision on both eyes reported a subscale score for “visual
functioning” which was about 14.23 units lower than in the case
of monocular visual impairment. Patients with one blind eye
reported a 29.24 units lower score. An increase of 1 unit in HRP
detection accuracy was accompanied by an increase in NEI-VFQ
“visual functioning” score of 0.29 units.
The regression of visual field parameters and NEI-VFQ “visual
functioning” on “mental-health symptoms due to vision prob-
lems” yielded only “visual functioning” as significant predictor
with an adjusted R2 of 0.38 (Table 2). An increase of 1 unit in the
“visual functioning” score was related to an increase of 0.64 units
in the “mental-health symptoms due to vision problems” score.
Regression of visual field parameters and NEI-VFQ results on
MCS and PCS was calculated separately. For hrQoL mean SF-12
MCS was 54.12 (SD= 7.98) and mean PCS 48.22 (SD= 8.02) and
thus significantly lowered with score differences of more than 25
compared to healthy control values from Bullinger and Kirch-
berger (1998). The NEI-VFQ score of “mental-health symptoms
due to vision problems” was significantly associated with the MCS
with an adjusted R2 of 0.30 (Table 2). An increase of 1 unit
in “mental-health symptoms due to vision problems” led to an
increase of 0.21 units in MCS. The model of the PCS demonstrated
similar results but a less distinct association with “mental-health
symptoms due to vision problems” with an adjusted R2 of 0.10. An
increased score of “mental-health symptoms due to vision prob-
lems” by one led to an increase of 0.14 units in PCS. For the PCS
reaction time in HRP and mean threshold in static perimetry were
significant predictors as well. The adjusted R2 for all significant
predictors was 0.18 (Table 2). A rise of 1 unit in reaction time led
to a decrease of 0.04 units in PCS. Similarly, an improvement about
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FIGURE 4 | Expected response frequencies and person parameters (weighted likelihood estimation,WLE) for self-reported “mental-health symptoms
due to vision problems” assessed with the respective NEI-VFQ subscale (sum score of five items). Person parameters (dotted line) lay between −4.00
and 4.49.
Table 2 | Summary of results from backward multiple linear regression models.
NEI-VFQ
“visual
functioning”
NEI-VFQ “mental-health
symptoms due to
vision problems”
SF-12 MCS SF-12 PCS
[Radj2=0.37,
F (3,94)=20.08,
p<0.01]
[Radj2=0.38,
F (1,96)=60.75,
p<0.01]
[Radj2=0.30,
F (1,93)=41.34,
p<0.01]
[Radj2=0.18,
F (4,90)=6.31,
p=0.01]
ß p ß p ß p ß p
Detection accuracy in HRP 0.38 <0.01 0.01 0.88 −0.11 0.24 0.16 0.47
Detection accuracy central 5° in HRP 0.15 0.39 −0.01 0.92 −0.12 0.19 −0.04 0.78
Reaction time in HRP 0.04 0.78 0.02 0.84 0.03 0.77 −0.38 0.01
Foveal threshold in static perimetry 0.11 0.26 0.05 0.53 −0.01 0.93 −0.10 0.41
Mean threshold in static perimetry 0.02 0.91 0.07 0.41 −0.14 0.12 −0.43 <0.01
Binocular impairment, both eyes residual vision −0.34 <0.01 −0.11 0.19 0.09 0.34 0.01 0.90
Binocular impairment, one blind eye −0.39 <0.01 0.07 0.41 −0.01 0.90 −0.17 0.08
NEI-VFQ visual functioning 0.62 <0.01 0.04 0.71 0.07 0.96
NEI-VFQ mental-health problems 0.55 <0.01 0.37 <0.01
p<0.05 in italics. Intercorrelations between visual field parameters in the regression for PCS lead to a negative ß-value for the mean threshold in static perimetry.
1 unit in mean threshold in static perimetry was accompanied by a
decrease of 0.54 units in PCS. Since some parameters were highly
intercorrelated, the regression weight of the mean threshold was
negative.
Path analysis revealed that HRP detection accuracy as a measure
of remaining visual field, predicts “visual functioning,” i.e., vrQoL
(R2= 0.22, ß= 0.46, p< 0.01) which in term is related to“mental-
health symptoms due to vision problems” (R2= 0.39, ß= 0.62,
p< 0.01). There is no significant path between HRP detection
accuracy and “mental-health symptoms due to vision problems”
(Figure 5). The model had a good data fit [χ2(1, n= 108)= 0.03,
p= 0.87, CFI= 1.00, RMSEA= 0.00].
DISCUSSION
With the present study we wished to determine to what extent
vrQoL decrements contribute to vision-related mental-health
symptoms. There were clinically relevant reductions of roughly 20
points concerning the NEI-VFQ subscale “mental-health symp-
toms due to vision problems” when comparing patients with
optic neuropathies to recently published healthy control sam-
ples without visual impairments (Labiris et al., 2008; Wagenbreth
et al., 2011). The most serious restrictions of mental health were
observed when asking for worries about vision which is in agree-
ment with a previous study showing that NEI-VFQ was associ-
ated with phobic anxiety in the SCL-90-R (r =−0.64, p< 0.01;
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FIGURE 5 | Path model with HRP detection accuracy and NEI-VFQ “visual functioning” as exogenous variables and NEI-VFQ “visual functioning” and
NEI-VFQ “mental-health symptoms due to vision problems” as endogenous variables.
Gall et al., 2012). In the present sample, the NEI-VFQ “visual
functioning” score was severely reduced as well.
Only the ocular functional state and HRP detection were related
to the“visual functioning” score. It may be concluded that monoc-
ular blindness is associated with more severe restrictions in every-
day activities that require some preserved binocular vision. As
expected a higher degree of remaining visual field was associ-
ated with a better score in subjective “visual functioning” and
therefore with fewer restrictions in everyday life. Indeed visual
field parameters were not found to be appropriate predictors for
mental-health concerns. Only NEI-VFQ “visual functioning” as
a measure of vrQoL significantly predicted “mental-health symp-
toms due to vision problems.”This finding could be expected since
both subscales are part of the same questionnaire.
As hypothesized, the proportion of explained variance by
“mental-health symptoms due to vision problems” was higher for
mental aspects of hrQoL (MCS of SF-12: 30%) than for physi-
cal aspects of hrQoL (PCS of SF-12: 10%) with higher ß-values
for MCS. For PCS reaction time in HRP and mean threshold in
static perimetry were significant predictors as well resulting in
an increase from 10 to 18% of explained variance. Here, further
parameters related to physical comorbidities are likely to have an
influence especially when an elderly sample is examined.
Using path analysis an indirect effect of remaining visual field
on mental-health problems via vrQoL was shown. This supports
the assumption that subjective consequences of visual impair-
ments in everyday life impact mental health rather than“objective”
visual function loss as measured in clinical settings. Similarly, in a
study by Zhang et al. (2013) subjective perception of visual field
impairments correlated with depression whereas visual acuity was
uncorrelated. We have recently shown that mental distress (mea-
sured with the SCL-90-R) was related to diminished vrQoL, but
it was actually not influenced by the extent of the visual field loss
itself (Gall et al., 2012) which is in agreement with the results of
the path analysis in the present study. Since regression and path
analysis are not suitable to draw conclusions about causality, a
model with inverse directions would fit, too. This also implies that
vision-impaired patients who are at risk for mental-health symp-
toms more likely suffer from reduced vrQoL due to the visual field
defect.
The obtained results are limited in several ways. Firstly, we have
studied a self-selected sample that participated in a clinical trial
with certain inclusion criteria. Furthermore, Rasch analysis was
conducted to ensure interval-scaled NEI-VFQ item responses for
subsequent analyses. The NEI-VFQ scales subjective “visual func-
tioning” suggested by Marella et al. (2010) and “mental-health
symptoms due to vision problems” both fitted with Rasch. How-
ever, we have studied only a small sample and observed only a
restricted number of different response patterns. Bootstrapping
allowed a more accurate decision about the model fit but a larger
sample size should be used to minimize this problem. Even when
the data fit to a proposed model, as in our study, it is not neces-
sarily the best model. Regression enabled to predict only 18–38%
of observed variance. VrQoL is a multidimensional construct by
definition. To be able to obtain a deeper understanding of mental-
health symptoms in vision loss the number and content of items
capturing mental-health symptoms should be expanded to more
precisely evaluate psychological distress that is associated with
vision loss.
Further analyses should consider more complex models to
avoid an omitted variable bias (Menard, 2002). Instead of using
averaged results of monocular visual field tests, binocular visual
fields are possibly more strongly related to subjective vision. Also
temporal processing deficits in the intact visual field may turn out
to be a relevant variable (Bola et al., 2013). Psychological variables,
like individual coping strategies or social resources, could be con-
sidered as possible confounders (Boerner and Wang, 2012). The
finding that elderly subjects with vision impairments had a poorer
level of depression, anxiety, and hrQoL despite the highest level of
social support (Kempen et al., 2012) points to the importance of
including measures of social support in the model.
There is evidence that diminished vrQoL is significantly related
to the severity of the visual field loss though the correlation is weak
to moderate (Papageorgiou et al., 2007; Gall et al., 2009). Reduc-
ing visual field loss by means of vision restoration techniques is
an important prerequisite to preserve or improve vrQoL. This
again may constitute a protective factor in maintaining mental
well-being despite the visual impairment. Participation in visual
rehabilitation and its early onset appears to have a preventive effect
on mental-health problems such as secondary depression in AMD
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(Mielke et al., 2013). Since the minimum lesion age in these studies
was 6 months and none of our patients received visual rehabilita-
tion prior to data acquisition we could not investigate the potential
effect of (early) rehabilitation onset on preservation of vrQoL
which is also an issue for future research. In fact, neuropsycholog-
ical training to reduce the visual field defect (Vision Restoration
Training, e.g., Sabel et al., 2011b) or to improve visual scanning
behavior in the area of partial blindness (eye movement training,
e.g., Nelles et al., 2010) are well known. It has not been studied yet
if patients with optic neuropathies develop compensatory strate-
gies on their own or receive other advice from low vision services
or eye specialists that may transfer into effective coping strategies
in everyday life and support to maintain vrQoL and mental health.
To improve health care for patients with optic neuropathies,
visual functional improvements should not be the only aim
but also the maintenance of vrQoL together with an ameliora-
tion of related mental-health symptoms. Proper assessment of
the respective symptoms together with systematic QoL assess-
ment is needed to identify the psychological needs of these
patients. Additionally the offer of psychosocial treatments should
be regularly provided for patients at risk for low QoL and
high levels of mental distress. The treatment of the visually
impaired should be an integrative approach encompassing vision
restoration and/or compensation treatments, teaching of effec-
tive coping strategies and, if necessary, supportive psychotherapy
aimed at reducing anxiety and depression. When vision restora-
tion is not sufficiently achieved, the aim should be to enhance
vrQoL to reduce mental distress even if vision loss cannot be
further improved.
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